Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia.

TitleDigital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia.
Publication TypeJournal Article
Year of Publication2019
AuthorsStarza IDella, De Novi LAnna, Santoro A, Salemi D, Tam W, Cavalli M, Menale L, Soscia R, Apicella V, Ilari C, Vitale A, Testi AMaria, Inghirami G, Chiaretti S, FoĆ  R, Guarini A
JournalLeuk Lymphoma
Volume60
Issue11
Pagination2838-2840
Date Published2019 11
ISSN1029-2403
KeywordsAntineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Combined Modality Therapy, Hematopoietic Stem Cell Transplantation, High-Throughput Nucleotide Sequencing, Humans, Neoplasm, Residual, Polymerase Chain Reaction, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prognosis
DOI10.1080/10428194.2019.1607325
Alternate JournalLeuk Lymphoma
PubMed ID31050551
Related Faculty: 
Giorgio Inghirami, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700